Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma, Ewing × alovudine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 10 Breast Neoplasms 8 Neoplasms 4 Head and Neck Neoplasms 3 Central Nervous System Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Uterine Cervical Neoplasms 2 Unspecified Adult Solid Tumor, Protocol Specific 2 Prostatic Neoplasms 2 Oligodendroglioma 2 Melanoma 2 Leukemia, Myeloid, Acute 2 Glioma 2 Glioblastoma 2 Ependymoma 2 Astrocytoma 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Ewing 1 Rectal Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Lymphoma 1 Lymphatic Metastasis 1 Lung Neoplasms 1 Hypoxia 1

Interventions

Cyclophosphamide 21 Temozolomide 19 Irinotecan 16 Vincristine 14 Doxorubicin 11 Topotecan 10 Melphalan 10 Etoposide 9 Busulfan 8 Ifosfamide 7 Granulocyte Colony-Stimulating Factor 7 Magnetic Resonance Spectroscopy 6 Filgrastim 6 cabozantinib 5 X-Rays 5 Sirolimus 5 Drug Therapy 5 pegfilgrastim 4 palbociclib 4 liposomal doxorubicin 4 fludarabine phosphate 4 fludarabine 4 Trabectedin 4 Specimen Handling 4 Phantoms, Imaging 4 Gemcitabine 4 regorafenib 3 irinotecan sucrosofate 3 ganitumab 3 abemaciclib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04067115 2025-12-17

U01CA236220

Sarcoma Alliance for Research through Collaboration

Phase 1/2 Completed

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡